Answers are grounded in this paper and cite their sources.
In 2008, three publications highlighted the transition of tolerance from experimental to experiential. These included the first study to both anticipate and reproducibly deliver human leukocyte antigen-disparate allograft survival without continuous immunosuppressive drug administration. The other two highlighted unique episodes of clinical tolerance. The results from these studies are summarized and discussed.
No takes yet. Share an insight, caveat, or question.
Allan D. Kirk (2009) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: